NewsRamp Editorial Team

NewsRamp Editorial Team

NewsRamp

@newsramp

NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.

4408 articles
Build a lasting personal brand

Articles

FAQ: Fullerton Health's Acquisition of The ENT Clinic in Singapore

FAQ: Fullerton Health's Acquisition of The ENT Clinic in Singapore

What is the main topic of this announcement? Fullerton Health has acquired The ENT Clinic, a leading Singapore-based otolaryngology (Ear, Nose & Throat) practice, to deepen its specialty care capabilities as part of its growth strategy. Why did Fullerton Health acquire The ENT Clinic? Fullerton Health identified ENT as one ...
January 7, 2026Read the full article
FAQ: TANDA Digital Named World's #1 Outbound Growth Partner for Marketing Agencies

FAQ: TANDA Digital Named World's #1 Outbound Growth Partner for Marketing Agencies

What is TANDA Digital and what achievement is being announced? TANDA Digital is a global outbound growth partner for specialist marketing and branding agencies that has been officially recognized as the world's number one outbound growth partner after helping more than 200 agencies scale client acquisition and generate pred...
January 7, 2026Read the full article
FAQ: Estrella Immunopharma's $8.0 Million Registered Direct Offering and Corporate Overview

FAQ: Estrella Immunopharma's $8.0 Million Registered Direct Offering and Corporate Overview

What is the main announcement in this content? Estrella Immunopharma has closed a registered direct offering generating approximately $8.0 million in gross proceeds through the issuance of shares, pre-funded warrants, and common warrants to a single healthcare-focused institutional investor. How much money did Estrella Immu...
January 7, 2026Read the full article
FAQ: American Heart Association's Response to the 2025-2030 Dietary Guidelines for Americans

FAQ: American Heart Association's Response to the 2025-2030 Dietary Guidelines for Americans

What is the main topic of this content? This content presents the American Heart Association's response to the newly released 2025-2030 Dietary Guidelines for Americans, highlighting areas of alignment and concern regarding heart-healthy eating recommendations. What specific recommendations in the new dietary guidelines doe...
January 7, 2026Read the full article
FAQ: SPARC AI Inc.'s Spatial Intelligence Technology and Target Acquisition Advancements

FAQ: SPARC AI Inc.'s Spatial Intelligence Technology and Target Acquisition Advancements

What is SPARC AI Inc. and what does it do? SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) is an emerging engineering and software company that develops and commercializes proprietary spatial and predictive AI technologies for real-world sensing applications, primarily focused on accurately determining the location of distant obje...
January 7, 2026Read the full article
FAQ: Safe & Green Holdings Corp. Rebranding to Olenox Industries Inc.

FAQ: Safe & Green Holdings Corp. Rebranding to Olenox Industries Inc.

What is the main announcement in this content? Safe & Green Holdings Corp. (NASDAQ: SGBX) announced a comprehensive corporate rebranding initiative that includes a planned name change to Olenox Industries Inc. and an update to its trading symbol. Why is Safe & Green Holdings rebranding to Olenox Industries? The rebranding r...
January 7, 2026Read the full article
Extend your brand profile by curating daily news.
FAQ: Del Rio's Infrastructure Development, Border Collaboration, and Economic Growth Strategy

FAQ: Del Rio's Infrastructure Development, Border Collaboration, and Economic Growth Strategy

In an audio-only episode of The Building Texas Show, Mayor Al Arreola discusses Del Rio’s next chapter—focusing on infrastructure, cross-border collaboration, Laughlin Air Force Base, and why this Texas border city is positioned for long-term economic growth.
January 7, 2026Read the full article
FAQ: Eric Herbst's Appointment as Chief Sales Officer at First Choice Garage Doors

FAQ: Eric Herbst's Appointment as Chief Sales Officer at First Choice Garage Doors

What is this announcement about? First Choice Garage Doors has appointed Eric Herbst as its new Chief Sales Officer (CSO), bringing his extensive industry experience to lead the company's sales operations and growth initiatives. Who is Eric Herbst and what experience does he bring? Eric Herbst has over 20 years of experienc...
January 7, 2026Read the full article
FAQ: Wearable Devices Ltd.'s Mudra Link Neural Wristband Updates and CES 2026 Plans

FAQ: Wearable Devices Ltd.'s Mudra Link Neural Wristband Updates and CES 2026 Plans

What is the main announcement from Wearable Devices Ltd.? Wearable Devices Ltd. has unveiled updates to its Mudra Link neural wristband, including new features and technology aimed at simplifying and standardizing interactions across the smart-glasses ecosystem. What specific technological advancement did Wearable Devices d...
January 7, 2026Read the full article
FAQ: Limited Market Exposure Tactics in Real Estate and Their Financial Impact on Sellers

FAQ: Limited Market Exposure Tactics in Real Estate and Their Financial Impact on Sellers

What is the main topic of this content? The content examines how real estate agents use limited market exposure tactics like "I have a buyer for your home" marketing, which can cost sellers substantial money by preventing competitive bidding scenarios that might yield higher offers. Who is Scott Spelker and what example doe...
January 7, 2026Read the full article
FAQ: BlockQuarry Corp.'s BLQCBuster(TM) Crypto Mining Platform Preorders and Market Response

FAQ: BlockQuarry Corp.'s BLQCBuster(TM) Crypto Mining Platform Preorders and Market Response

What is the main topic of this announcement? The announcement covers BlockQuarry Corp.'s report of strong market response to preorders for its BLQCBuster(TM) crypto mining platform, including significant interest from institutional and enterprise-scale operators. Why is there strong market interest in the BLQCBuster(TM) pla...
January 7, 2026Read the full article
FAQ: Wearable Devices Ltd. and Rokid Collaboration for Gesture-Controlled AI/AR Glasses

FAQ: Wearable Devices Ltd. and Rokid Collaboration for Gesture-Controlled AI/AR Glasses

What is the main announcement in this content? Wearable Devices Ltd. (NASDAQ: WLDS) has announced a collaboration with Rokid to enable gesture control for AI and AR glasses using Wearable Devices' Mudra Link neural wristband. Who are the companies involved in this collaboration? The collaboration involves Wearable Devices L...
January 7, 2026Read the full article
Extend your brand profile by curating daily news.
FAQ: Datavault AI's Collaboration with Riflessi for Immersive Retail Technology

FAQ: Datavault AI's Collaboration with Riflessi for Immersive Retail Technology

What is the main announcement in this content? Datavault AI Inc. (NASDAQ: DVLT) announced a collaboration with Riflessi, a premium Fifth Avenue retail destination in New York City, to deploy DVHOLO™ holographic display platform and ADIO® spatial audio technology beginning in February 2026. What is Datavault AI's business fo...
January 7, 2026Read the full article
FAQ: A2Z Cust2Mate Solutions Corp.'s $20 Million Share Repurchase Program

FAQ: A2Z Cust2Mate Solutions Corp.'s $20 Million Share Repurchase Program

What is the main announcement from A2Z Cust2Mate Solutions Corp.? The company's board of directors has approved a share repurchase program authorizing the repurchase of up to $20 million of its outstanding common shares over a period of up to three months. Why is A2Z Cust2Mate implementing this share repurchase program? The...
January 7, 2026Read the full article
FAQ: Scinai Immunotherapeutics CEO's Role in HealthIL Week 2026 Biopharma Manufacturing Roundtable

FAQ: Scinai Immunotherapeutics CEO's Role in HealthIL Week 2026 Biopharma Manufacturing Roundtable

What is the main announcement in this content? Scinai Immunotherapeutics announced that CEO Amir Reichman will co-lead a roundtable discussion titled 'Biopharma Manufacturing in Israel: Capabilities, Gaps, and Scale' during HealthIL Week 2026. Who is Amir Reichman and what company does he represent? Amir Reichman is the Chi...
January 7, 2026Read the full article
FAQ: Maduro's Capture and Its Impact on Gold Prices

FAQ: Maduro's Capture and Its Impact on Gold Prices

What is the main topic of this content? The content discusses how the capture of Venezuelan President Nicolas Maduro by the U.S. triggered a rally in precious metals prices, particularly gold, due to investor concerns about geopolitical implications. Why did gold prices increase after Maduro's capture? Gold prices rallied b...
January 7, 2026Read the full article
FAQ: AI Use in Schools and the Lag in Guidance

FAQ: AI Use in Schools and the Lag in Guidance

What is the main topic of this content? The content discusses how AI use in schools has exploded, becoming an everyday learning and teaching assistant, but highlights that guidance and rules are lagging behind this rapid technological growth. How are students using AI in schools according to the content? Students are using ...
January 7, 2026Read the full article
FAQ: Preclinical Study on Combination Therapy for Glioblastoma Treatment

FAQ: Preclinical Study on Combination Therapy for Glioblastoma Treatment

What is the main topic of this content? The content discusses a preclinical study suggesting a combination therapy could treat glioblastoma, an aggressive brain cancer, developed by University of North Carolina researchers. What specific combination therapy shows promise against glioblastoma? The therapy pairs a standard ch...
January 7, 2026Read the full article
FAQ: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Clinical Development and Strategic Updates

FAQ: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Clinical Development and Strategic Updates

What is LIXTE Biotechnology Holdings Inc. and what does it do? LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) is a clinical-stage pharmaceutical company developing differentiated cancer therapies built around a novel biological target, specifically advancing a first-in-class PP2A inhibitor platform designed to enhance est...
January 7, 2026Read the full article
FAQ: Lixte Biotechnology's $4.3 Million Registered Direct Offering and Company Overview

FAQ: Lixte Biotechnology's $4.3 Million Registered Direct Offering and Company Overview

What is the main announcement in this content? Lixte Biotechnology Holdings announced a $4.3 million registered direct offering with accredited investors for the purchase and sale of Common Stock and pre-funded and investor warrants priced at $4.09 per Common Unit. How much money did Lixte Biotechnology raise and what will ...
January 7, 2026Read the full article
FAQ: Ricky Gleason's Campaign for Kendall County Judge

FAQ: Ricky Gleason's Campaign for Kendall County Judge

Ricky Gleason has announced his candidacy for Kendall County Judge, focusing his platform on protecting property rights and implementing mindful growth strategies to preserve the community's unique character. A local financial advisor rooted in faith and family values, Gleason pledges to lead with transparency and fiscal re...
January 7, 2026Read the full article

Showing 1639-1659 of 4408 articles (Page 79 of 210)